ArticleCancer biology & therapy2015

Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.

Ting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.